Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
644,194
-
Share change
-
+644,194
-
Total reported value
-
$2,111,000
-
Price per share
-
$3.28
-
Number of holders
-
7
-
Value change
-
+$2,111,015
-
Number of buys
-
7
Institutional Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q4 2019
As of 31 Dec 2019,
Protalix BioTherapeutics, Inc. - COM (PLX) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
644,194 shares.
The largest 8 holders included
RENAISSANCE TECHNOLOGIES LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Measured Wealth Private Client Group, LLC, JANE STREET GROUP, LLC, SG Americas Securities, LLC, FEDERATED HERMES, INC., GROUP ONE TRADING, L.P., and Federation des caisses Desjardins du Quebec.
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.